AMIRA 

 

BARKAL 

EXECUTIVE OFFICER, DIRECTOR

PHEAST THERAPEUTICS, INC.

STEVEN 

 

GILLIS 

DIRECTOR

TRUBION PHARMACEUTICALS, INC   |  PHASERX INC   |  PULMATRIX INC   |  THERACLONE SCIENCES, INC.   |  MIRINA CORP   |  SURFACE LOGIX INC   |  ACYLIN THERAPEUTICS, INC.   |  BLUEBIRD BIO, INC.   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  GROOVE BIOPHARMA CORP   |  ALLOZYNE INC   |  PHASERX, INC.   |  VIRAL LOGIC SYSTEMS TECHNOLOGY CORP   |  FARADAY PHARMACEUTICALS, INC.   |  PULMATRIX OPERATING COMPANY, INC.   |  LYCERA CORP   |  PULMATRIX, INC.   |  NEXGENIA INC.   |  CODIAK BIOSCIENCES, INC.   |  VBI VACCINES INC/BC   |  NOHLA THERAPEUTICS INC.   |  HOMOLOGY MEDICINES, INC.   |  IMMUSANT, INC.   |  ONCORESPONSE INC   |  EGENESIS, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  HC BIOSCIENCE, INC.   |  ARCH VENTURE FUND XII, L.P.   |  PHEAST THERAPEUTICS, INC.   |  SONOTHERA, INC.   |  PRONIRAS CORP   |  ONCORESPONSE, INC

THOMAS 

 

MARTY 

EXECUTIVE OFFICER

PHEAST THERAPEUTICS, INC.

ROY 

 

MAUTE 

EXECUTIVE OFFICER, DIRECTOR

PHEAST THERAPEUTICS, INC.

RAPHAEL 

 

ROUSSEAU 

EXECUTIVE OFFICER

PHEAST THERAPEUTICS, INC.

JACOB 

 

VOGELSTEIN 

DIRECTOR

SISU GLOBAL HEALTH INC.   |  PHEAST THERAPEUTICS, INC.

IRVING 

 

WEISSMAN 

DIRECTOR

FORTY SEVEN, INC.   |  PHEAST THERAPEUTICS, INC.